Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

BTAI

BioXcel Therapeutics (BTAI)

BioXcel Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BTAI
DateTimeSourceHeadlineSymbolCompany
11/03/202522:00GlobeNewswire Inc.BioXcel Therapeutics Strengthens Cash Position to Advance SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or SchizophreniaNASDAQ:BTAIBioXcel Therapeutics Inc
07/03/202523:00GlobeNewswire Inc.BioXcel Therapeutics Announces 33% Enrollment in SERENITY At-Home Pivotal Phase 3 Safety TrialĀ for Acute Treatment of Agitation Associated with Bipolar Disorders or SchizophreniaNASDAQ:BTAIBioXcel Therapeutics Inc
05/03/202508:15GlobeNewswire Inc.BioXcel Therapeutics Announces Closing of $14 Million Registered Direct OfferingNASDAQ:BTAIBioXcel Therapeutics Inc
05/03/202500:51Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BTAIBioXcel Therapeutics Inc
04/03/202507:33GlobeNewswire Inc.BioXcel Therapeutics Announces $14 Million Registered Direct OfferingNASDAQ:BTAIBioXcel Therapeutics Inc
04/03/202500:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BTAIBioXcel Therapeutics Inc
03/03/202523:00GlobeNewswire Inc.BioXcel Therapeutics Announces FDA Closed its Inspection of Site for PhaseĀ 3 TRANQUILITY II Trial for Acute Treatment of Agitation Associated with Alzheimerā€™s DementiaNASDAQ:BTAIBioXcel Therapeutics Inc
28/02/202523:00GlobeNewswire Inc.BioXcel Therapeutics Regains Compliance with Nasdaq Minimum Bid Price RuleNASDAQ:BTAIBioXcel Therapeutics Inc
07/02/202500:44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BTAIBioXcel Therapeutics Inc
06/02/202523:00GlobeNewswire Inc.BioXcel Therapeutics Announces Reverse Stock SplitNASDAQ:BTAIBioXcel Therapeutics Inc
05/02/202523:00GlobeNewswire Inc.BioXcel Therapeutics Provides Clinical and Business UpdateNASDAQ:BTAIBioXcel Therapeutics Inc
30/01/202508:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BTAIBioXcel Therapeutics Inc
21/01/202516:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BTAIBioXcel Therapeutics Inc
17/01/202500:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BTAIBioXcel Therapeutics Inc
11/01/202512:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BTAIBioXcel Therapeutics Inc
11/01/202512:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BTAIBioXcel Therapeutics Inc
11/01/202508:45Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BTAIBioXcel Therapeutics Inc
08/01/202523:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BTAIBioXcel Therapeutics Inc
31/12/202408:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BTAIBioXcel Therapeutics Inc
19/12/202409:16Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BTAIBioXcel Therapeutics Inc
18/12/202410:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BTAIBioXcel Therapeutics Inc
18/12/202410:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BTAIBioXcel Therapeutics Inc
18/12/202410:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BTAIBioXcel Therapeutics Inc
17/12/202407:59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BTAIBioXcel Therapeutics Inc
17/12/202407:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BTAIBioXcel Therapeutics Inc
17/12/202406:10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BTAIBioXcel Therapeutics Inc
26/11/202408:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BTAIBioXcel Therapeutics Inc
25/11/202422:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BTAIBioXcel Therapeutics Inc
23/11/202400:16GlobeNewswire Inc.BioXcel Therapeutics Announces Pricing of $7.0 Million Public OfferingNASDAQ:BTAIBioXcel Therapeutics Inc
22/11/202408:47GlobeNewswire Inc.BioXcel Therapeutics Announces Proposed Public OfferingNASDAQ:BTAIBioXcel Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:BTAI